Xuya Wang
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Spatial enrichment of PTPRZ1 in the peritumoral niche drives glioblastoma migration via the OPA1/ROS/CDH2 axis.
Journal: Journal of translational medicine
Published: April 19, 2026
The perinecrotic niche of glioblastoma drives tumor-associated macrophage polarization and immunosuppression via podoplanin-mediated CLEC5A activation.
Journal: The Journal of clinical investigation
Published: August 19, 2025
Correction: FGFR3-TACC3 fusion gene promotes glioblastoma malignant progression through the activation of STAT3 signaling pathway.
Journal: Frontiers in oncology
Published: May 30, 2025
Interrogation of macrophage-related prognostic signatures reveals a potential immune-mediated therapy strategy by histone deacetylase inhibition in glioma.
Journal: Frontiers in oncology
Published: January 03, 2025
GPR65 contributes to constructing immunosuppressive microenvironment in glioma.
Journal: Neurosurgical review
Published: November 01, 2023
NCAPH serves as a prognostic factor and promotes the tumor progression in glioma through PI3K/AKT signaling pathway.
Journal: Molecular and cellular biochemistry
Published: September 26, 2023
TCAF2 drives glioma cellular migratory/invasion properties through STAT3 signaling.
Journal: Molecular and cellular biochemistry
Published: August 03, 2023
A Novel Prognostic Signature Based on Glioma Essential Ferroptosis-Related Genes Predicts Clinical Outcomes and Indicates Treatment in Glioma.
Journal: Frontiers in oncology
Published: March 16, 2022
PDPN contributes to constructing immunosuppressive microenvironment in IDH wildtype glioma.
Journal: Cancer gene therapy
Published: February 17, 2022
Last Updated: 09/26/2026